A racial difference in the prevalence of the Arg506 - >Gln mutation

Thrombosis Research

Volumn 81, Issue 5, 1996, Pages 577-581

  Hooper, W Craig ^a,e   Dilley, Anne ^a,b   Ribeiro, Maria J A ^a,b   Benson, Jane ^a   Austin, Harland ^a,b   Silva, Victor ^c   Rawlins, Peggy ^c   Wenger, Nanette K ^c,d   Evatt, Bruce L ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY   (United States)

^c GRADY MEMORIAL HOSPITAL   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

APC R; Protein C; Race prevalence; Thrombosis

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ARGININE; BASE SEQUENCE; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR V; GLYCINE; HUMANS; MOLECULAR SEQUENCE DATA; POINT MUTATION;

EID: 0029877879     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00032-1     Document Type: Article

References (10)

1. GRIFFIN JH, EVATT B, WIDEMAN C, FERNANDEZ JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82:1989-93, 1983.
2. KOSTER T, ROSENDAAL FR, DE RONDER H, BRIET E, VANDENBROUCKE JP, BERTINA RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503-06, 1993.
3. SVENSSON PJ, DAHLBACK B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517-22, 1994.
4. BERTINA M, KOELEMAN BP, KOSTER, T, ROSENDAAL FR, DIRVEN RJ, DERONDE H, VONDERVELDEN PA, REITSMA PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 365:64-67, 1994.
5. DAHLBACK B. Resistance to activated protein C, the ARG506 to gin mutation in the factor V gene, and venous thrombosis. Thrombosis and Haemostasis 73:739-42, 1995.
6. RIDKER PM, HENNEKENS CH, LINDPAINTNER K, STAMPFER MJ, EISENBERG PR, MILETICH JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J of Med 332:912-17, 1995.
7. NICKERSON DA, KAISER R, LAPPIN S, STEWART J, HOOD L. Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci USA 89:23-27, 1990.
8. ROTHMAN, KJ. Modern Epidemiology. Little, Brown, and Company, Boston (1986).
9. Healthy People 2000: National health promotion and disease prevention objectives. U.S. Dept of Health and Human Services, Public Health Service 1990.
10. SALZMAN, EW, HERSCH J. The epidemiology, pathogenesis and natural history of venous thrombosis. In: Hemostasis and Thrombosis, R.W. Colman (ed.), Hirsch J, Marder VJ, Salzman EW. p1275, JB Lippincott Co, Philadelphia (1994) .